4.6 Review

International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function

Journal

PHARMACOLOGICAL REVIEWS
Volume 73, Issue 1, Pages 310-520

Publisher

AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/pr.118.015552

Keywords

-

Funding

  1. Ministry of Defence [JFC7a/00018]
  2. University of Birmingham
  3. Celentyx Ltd.
  4. Centre national de la recherche scientifique (France)
  5. Institut national de la sante et de la recherche medicale (France)
  6. University of Montpellier
  7. Fondation pour la Recherche Medicale [DPA20140629800]
  8. l'Agence nationale de la recherche (France) [ANR-11-BSV4-008-01, ANR-12-BSV4-0008-01, ANR-17-CE16-0013-01, ANR-17-CE16-0010]
  9. France Alzheimer
  10. Languedoc Roussillon region
  11. Fondation Plan Alzheimer
  12. Fondation Vaincre Alzheimer [12721, FR-15072]
  13. National Institutes of Health National Institute on Drug Abuse [T32 DA007287, P50 DA033935, K05 DA020087]
  14. Banting and Best Canada Graduate Scholarship from the Canadian Institutes of Health Research
  15. South-Eastern Norway Regional Health Authority
  16. Norwegian Council on Cardiovascular Diseases
  17. Research Council of Norway
  18. Kristian Gerhard Jebsen Foundation
  19. Anders Jahre's Foundation for the Promotion of Science
  20. Family Blix foundation
  21. Simon Fougner Hartmann Family Foundation
  22. University of Oslo
  23. European Research Council
  24. Consejo Nacional de Ciencia y Tecnologia [219707]
  25. University of Melbourne
  26. Hallmark initiative
  27. National Health and Medical Research Council (Australia) [APP1105284, APP1105332]
  28. Alzheimer's Association
  29. Royal Australian College of General Practitioners Ltd foundation (Australia)
  30. Agence Nationale de la Recherche (ANR) [ANR-17-CE16-0013, ANR-17-CE16-0010, ANR-12-BSV4-0008] Funding Source: Agence Nationale de la Recherche (ANR)

Ask authors/readers for more resources

This review provides a comprehensive account of the classification and function of 5-hydroxytryptamine receptors, including how they are targeted for therapeutic benefit.
5 HT receptors expressed throughout the human body are targets for established therapeutics and various drugs in development. Their diversity of structure and function reflects the important role 5-HT receptors play in physiologic and pathophysiological processes. The present review offers a framework for the official receptor nomenclature and a detailed understanding of each of the 14 5-HT receptor subtypes, their roles in the systems of the body, and, where appropriate, the (potential) utility of therapeutics targeting these receptors. Significance Statement-This review provides a comprehensive account of the classification and function of 5-hydroxytryptamine receptors, including how they are targeted for therapeutic benefit.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available